+61 8 8302 2493
Anton is a research and teaching academic, and the Applied Chemistry and Translational Biomaterials (ACTB) Group leader at the Clinical and Health Sciences (CHS) Unit at the University of South Australia (UniSA). His research group works at the interface between chemistry, biomaterials and pharmaceutical sciences to develop innovative solutions to current and emerging biomedical and environmental challenges. Anton also teaches into first year chemistry, and second year analytical and organic chemistry courses.
The ACTB Group has a strong focus on the translation of fundamental principles to applied outputs and end-user informed solutions. Currently the group is collaborating with various biotech (Carina... Read more
About me
Anton is a research and teaching academic, and the Applied Chemistry and Translational Biomaterials (ACTB) Group leader at the Clinical and Health Sciences (CHS) Unit at the University of South Australia (UniSA). His research group works at the interface between chemistry, biomaterials and pharmaceutical sciences to develop innovative solutions to current and emerging biomedical and environmental challenges. Anton also teaches into first year chemistry, and second year analytical and organic chemistry courses.
The ACTB Group has a strong focus on the translation of fundamental principles to applied outputs and end-user informed solutions. Currently the group is collaborating with various biotech (Carina Biotech; Vetter Pharm.; D&R Pharm.; CRC CTM) and conservation (FAME; Ecological Horizons) groups to develop innovative technologies to deliver more efficient, efficacious and sustainable processes.
After completing a PhD in Organic and polymer chemistry from the University of Reading (UK) under the supervision of Prof. Wayne Hayes in 2006, Anton joined the Polymer Science Group at the University of Melbourne as a Postdoctoral Fellow, where he worked on several CRCs (CRC for Polymers; Cotton Catchment Communities CRC) and ARC Linkage (DuPont; PolyActiva) funded projects. In 2009, he was awarded an Australian Research Council Postdoctoral Fellowship. In 2013, Anton moved to UniSA as a Senior Research Fellow to contribute and manage several CRC projects (Vision CRC; Wound Management Innovation CRC; CRC for Cell Therapy Manufacturing (CTM)), before joining Pharmacy School (now CHS) in 2015 to establish the ACTB Group.
About me
American Chemical Society, Royal Australian Chemical Institute
About me
Doctor of Philosophy University of Reading
Master of Chemistry University of Reading
My group's main focus revolves around the development of biomaterials and bioconjugation strategies for applications in regenerative medicine, 3D-bioprinting and tissue engineering. This research is underpinned by a strong foundation in fundamental chemistry and polymer science, and a passion to develop real-world solutions to the challenges facing society and the environment.
Research
Excludes commercial-in-confidence projects.
S12: Air bubble interactions with oil modified composite mineral surfaces, ARC - Centre of Excellence, 01/07/2023 - 31/12/2028
S30: Polymers with Switchable Adsorbed Layer Properties for Selective Separation of Minerals, ARC - Centre of Excellence, 01/07/2023 - 31/12/2028
Reducing the impact of foxes on vulnerable native mammal populations using conditioned odour aversion, ESA-Holsworth Wildlife Research Endowment, 02/09/2024 - 30/01/2026
Unlocking complex resources through lean processing, BHP Billiton Olympic Dam Corporation Pty Ltd, 01/06/2018 - 31/08/2024
Unlocking complex resources through lean processing, SA Dept of Innovation and Skills (formerly DSD), 01/06/2018 - 31/08/2024
ARC Training Centre for Integrated Operations for Complex Resources, ARC - Industrial Transformation Training Centres, 27/08/2020 - 26/08/2024
Native Fauna Population Protecting Implants, Nature Foundation SA, 01/04/2020 - 06/08/2021
Cell Therapy Manufacturing CRC Scholarship, Cell Therapy Manufacturing CRC, 23/02/2016 - 31/12/2019
CRC-P Delivery gel lead optimization: chemical formulation, Carina Biotech, 01/01/2019 - 31/12/2019
Cell Therapy Manufacturing CRC Scholarship, Cell Therapy Manufacturing CRC, 29/05/2017 - 30/06/2019
CTM 1-17 A gel formulation for localised delivery of car-t cells (part 2), Cell Therapy Manufacturing CRC, 01/03/2017 - 30/03/2018
Global connections fund priming grant, Australian Academy of Technology and Engineering, 01/07/2016 - 31/07/2017
1-05 Materials and smart surfaces for enhanced islet survival, transport and transfer, Cell Therapy Manufacturing CRC, 01/01/2014 - 31/12/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2019 |
|
2019 |
|
2018 |
4
|
Year | Output |
---|---|
2024 |
|
2024 |
Open access
|
2024 |
Open access
|
2024 |
Open access
|
2024 |
Open access
|
2024 |
Open access
1
|
2024 |
1
|
2024 |
3
|
2023 |
Open access
1
79
|
2023 |
Open access
2
1
4
|
2023 |
Open access
7
7
1
|
2023 |
Open access
1
5
|
2023 |
5
|
2023 |
Open access
3
2
2
|
2023 |
Open access
3
5
|
2023 |
6
7
6
|
2023 |
Open access
1
1
5
|
2022 |
5
5
72
|
2022 |
Open access
7
7
2
|
2022 |
Open access
3
3
5
|
2022 |
Open access
6
6
7
|
2022 |
Open access
1
7
|
2022 |
Open access
15
13
1
|
2022 |
Open access
11
13
4
|
2021 |
Open access
16
15
1
|
2021 |
Open access
6
7
|
2021 |
Open access
34
28
|
2021 |
Open access
7
6
|
2021 |
23
21
4
|
2021 |
Open access
10
10
4
|
2021 |
6
7
4
|
2021 |
3
3
4
|
2021 |
Open access
15
14
|
2021 |
Open access
6
4
1
|
2020 |
139
99
1
|
2020 |
Open access
21
21
4
|
2020 |
Open access
17
18
2
|
2020 |
10
8
|
2020 |
Open access
10
9
1
|
2020 |
Open access
26
17
99
|
2020 |
12
11
|
2020 |
13
12
2
|
2019 |
Open access
26
22
1
|
2019 |
Open access
4
|
2019 |
157
134
3
|
2019 |
Open access
14
14
3
|
2019 |
71
67
4
|
2019 |
14
12
1
|
2019 |
Open access
18
18
1
|
2018 |
1
|
2018 |
Open access
8
8
|
2018 |
Open access
7
6
35
|
2018 |
Open access
9
8
|
2017 |
89
71
64
|
2017 |
Open access
16
18
27
|
2017 |
19
17
25
|
2017 |
12
11
28
|
2017 |
Open access
22
24
7
|
2017 |
12
11
1
|
2017 |
Open access
43
43
4
|
2016 |
9
8
2
|
2016 |
38
38
6
|
2016 |
37
30
4
|
2016 |
624
606
750
|
2016 |
66
64
|
2016 |
4
4
|
2016 |
518
495
224
|
2016 |
Open access
9
9
|
2016 |
17
16
|
2016 |
Open access
18
17
|
2016 |
Open access
20
20
|
2015 |
13
12
|
2015 |
13
12
|
2015 |
17
15
1
|
2015 |
14
15
7
|
2015 |
19
19
|
2015 |
52
49
|
2015 |
Open access
13
14
|
2015 |
Open access
9
21
|
2014 |
1
1
|
2014 |
Open access
5
5
10
|
2014 |
Open access
13
12
|
2014 |
Open access
9
7
|
2014 |
59
58
1
|
2014 |
Open access
25
22
3
|
2014 |
Open access
11
11
|
2014 |
Open access
146
144
15
|
2013 |
Open access
3
3
|
2013 |
34
30
|
2013 |
Open access
37
28
|
2013 |
24
22
|
2013 |
1
1
|
2013 |
23
21
|
2013 |
Open access
31
28
|
2013 |
Open access
17
16
|
2013 |
Open access
13
12
|
2013 |
2
3
|
2013 |
115
106
|
2013 |
43
41
|
2013 |
13
13
|
2013 |
Open access
14
17
|
2013 |
31
32
|
2013 |
Open access
17
17
|
2013 |
33
30
|
2012 |
23
20
|
2012 |
40
38
|
2012 |
22
23
|
2012 |
48
46
|
2012 |
44
43
|
2012 |
27
27
|
2012 |
65
62
|
2012 |
29
27
|
2012 |
27
29
|
2012 |
23
22
|
2012 |
24
23
|
2011 |
39
38
|
2011 |
21
21
|
2011 |
20
18
|
2011 |
44
44
|
2011 |
42
41
|
2011 |
30
29
|
2011 |
6
4
|
2011 |
6
6
|
2011 |
111
103
|
2011 |
70
68
|
2010 |
57
53
|
2010 |
|
2010 |
9
6
|
2009 |
1
1
|
2009 |
Open access
391
380
|
2009 |
Open access
|
2009 |
39
37
|
2009 |
17
17
|
2008 |
9
9
|
2008 |
27
26
|
2008 |
16
15
|
2008 |
14
13
|
2008 |
54
50
|
2008 |
6
5
|
2008 |
41
39
|
Year | Output |
---|---|
2016 |
Open access
6
4
|
2015 |
Open access
5
5
|
2015 |
|
2011 |
|
Research
My group's main focus revolves around the development of biomaterials and bioconjugation strategies for applications in regenerative medicine, 3D-bioprinting and tissue engineering. This research is underpinned by a strong foundation in fundamental chemistry and polymer science, and a passion to develop real-world solutions to the challenges facing society and the environment.
Research
Details | Registry | Status |
---|---|---|
Method for controlling water evaporation Solomon, David Henry; Prime, Emma Louise; Sunartio, Devi; Qiao, Greg Guanghua; Dagley, Ian; Blencowe, Anton |
AU | Granted |
Process for the preparation of a cross-linked multilayer film Caruso, Francesco; Qiao, Greg Guanghua; Blencowe, Anton Richard; Goh, Tor Kit; Connal, Luke Andrew; Such, Georgina Kate |
US | Granted |
External engagement & recognition
Organisation | Country |
---|---|
Aethers Industries | UNITED STATES |
Alfred Health | AUSTRALIA |
Australian National University | AUSTRALIA |
Australian Nuclear Science and Technology Organisation | AUSTRALIA |
Australian Radiation Protection and Nuclear Safety Agency | AUSTRALIA |
Australian Synchrotron | AUSTRALIA |
Bangor University | UNITED KINGDOM |
BolderPATH, Inc. | UNITED STATES |
Botswana International University of Science and Technology | BOTSWANA |
CSIRO Australia (Commonwealth Scientific Industrial Research organisation) | AUSTRALIA |
Ecological Horizons | AUSTRALIA |
Fleet Bioprocessing | UNITED KINGDOM |
Flinders University | AUSTRALIA |
Garvan Institute of Medical Research | AUSTRALIA |
Helmholtz Virtual Institute on Multifunctional Biomaterials for Medicine | GERMANY |
Institut Charles Sadron | FRANCE |
Institute of Cancer Research | UNITED KINGDOM |
Kimberly-Clark | AUSTRALIA |
Kobe University | JAPAN |
Melbourne Dental School | AUSTRALIA |
Monash Institute of Pharmaceutical Sciences | AUSTRALIA |
Monash University | AUSTRALIA |
Nagoya University | JAPAN |
National Institute for Materials Science | JAPAN |
National Institute of Health and Medical Research-INSERM | FRANCE |
National Institutes of Health | UNITED STATES |
North Carolina State University - Raleigh | UNITED STATES |
O’Brien Institute | AUSTRALIA |
O'Brien Institute | AUSTRALIA |
PolyActiva P/L | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Rheinisch-Westfaelische Technische Hochschule University Hospital Aachen | GERMANY |
Rider University | UNITED STATES |
RMIT University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal North Shore Hospital | AUSTRALIA |
Royal Victorian Eye and Ear Hospital | AUSTRALIA |
School of Chemical Engineering | AUSTRALIA |
Seattle Children's Hospital | UNITED STATES |
Shandong University | CHINA |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
St. Vincent's Institute of Medical Research | AUSTRALIA |
The James Hutton Institute | UNITED KINGDOM |
Tshwane University of Technology | SOUTH AFRICA |
Universitat Freiburg im Breisgau | GERMANY |
Universiteit van Pretoria | SOUTH AFRICA |
University Medical Centre Freiburg | GERMANY |
University of Adelaide | AUSTRALIA |
University of Applied Sciences and Arts Northwestern Switzerland | SWITZERLAND |
University of Basel | SWITZERLAND |
University of Freiburg | GERMANY |
University of Houston | UNITED STATES |
University of Johannesburg | SOUTH AFRICA |
University of Melbourne | AUSTRALIA |
University of New South Wales | AUSTRALIA |
University of Pretoria | SOUTH AFRICA |
University of Queensland | AUSTRALIA |
University of Reading | UNITED KINGDOM |
University of Science, Malaysia | MALAYSIA |
University of Siena | ITALY |
University of South Australia | AUSTRALIA |
University of Strasbourg | FRANCE |
University of Surrey | UNITED KINGDOM |
University of Texas | UNITED STATES |
University of Texas MD Anderson Cancer Centre | UNITED STATES |
University of Tokyo | JAPAN |
Yale University | UNITED STATES |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Deputy Chair of the Australian Synchrotron User Advisory CommiteeAustralian Nuclear Science and Technology Organisation (ANSTO) |
2024 |
Deputy Chair of the Australian Synchrotron User Advisory CommiteeAustralian Nuclear Science and Technology Organisation (ANSTO) |
2023 |
Deputy Chair of the Australian Synchrotron User Advisory CommiteeAustralian Nuclear Science and Technology Organisation (ANSTO) |
2022 |
MemberAmerican Chemical Society (ACS) |
2018 |
MemberRoyal Society of Chemistry |
2018 |
Honorary Senior FellowUniversity of Melbourne |
2017 |
MemberAmerican Chemical Society (ACS) |
2017 |
MemberRoyal Society of Chemistry |
2017 |
Honorary Senior FellowUniversity of Melbourne |
2016 |
Honorary Senior FellowUniversity of Melbourne |
2015 |
Honorary Senior FellowUniversity of Melbourne |
2014 |
Honorary Senior FellowUniversity of Melbourne |
2013 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
106660- Wetting, spreading, and adhesion of oils on composite mineral surfaces | Current |
106817 -Application of synthetic and biopolymers in selective recovery of minerals | Current |
108311-Ultrathin ionic liquid films on surfaces | Current |
110508 - Interfacial crystallization of lipids in food formulations | Current |
111081 - Introducing a new paradigm for specific targeting of ovarian cancer cells with engineered nanoparticles, using G protein-coupled receptors as molecular entry points | Current |
Bettering the devil ¿ Innovative strategies to protect livestock and native animals from introduced predators | Current |
Decorated cubosomes for anti-cancer drugs delivery and targeting | Current |
Development of a novel controlled release anticancer drugs delivery system using 3D printing | Current |
Development of bio-polymer collectors and depressants for selective mineral flotation | Current |
Precise antibody-drug conjugates for the targeted treatment of disease | Current |
Sensing metal ions with polyelectrolyte multilayer films | Current |
Targeting ovarian cancer with nanoparticle drug carriers using G protein-coupled receptors as molecular entry sites | Current |
Thermal efficiency improvements of electrocaloric cooling using an electrohydrodynamic egenerative heat exchanger | Current |
Development of a pH-responsive implant for the targeted control of feral cats and the protection of native mammals | Completed |
Development of drug-eluting stents for the localised delivery of 5-fluorouracil targeted towards the treatment of gastrointestinal cancers | Completed |
Development of drug-eluting stents using dip-coating and 3D printing techniques for the localised treatment of oesophageal cancer | Completed |
Development of injectable hydrogels for the delivery of therapeutic agents | Completed |
Development of pH-responsive polymer-homopolypeptide micelles for drug delivery | Completed |
Development of thermoresponsive polysaccharides as tunable delivery systems | Completed |
Fundamental studies of poly(ethylene glycol-b-caprolactone) block copolymers self-assembly in water | Completed |
Hyperbranched polyglycerol at the biointerface | Completed |
Interplay of an antifungal coating and surface micro-cone structure on the biological responses of attaching fungal and mammalian cells | Completed |
Investigation and development of pentafulvene-maleimide ligation for bioconjugation | Completed |
Teaching an old dog new tricks: a global approach to enhancing the cytotoxicity of drug-loaded, non-responsive micelles using oligoelectrolytes | Completed |